MIRM Mirum Pharmaceuticals
- 25.920
- -0.760-2.85%
- 25.920
- 0.0000.00%
Mirum Pharmaceuticals News
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GREY MICHAEL G
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Walbert Timothy P
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cardon Lon
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brege Laura
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Heron Patrick J
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fischer Laurent
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ramasastry Saira
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fairey William
Mirum Pharmaceuticals | 8-K: Current report
Mirum Pharmaceuticals | 8-K: Current report
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Vig Pamela
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Peetz Christopher
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer BJERKHOLT ERIC
Mirum Pharmaceuticals | 10-Q: Quarterly report
Mirum Pharmaceuticals | 8-K: Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Mirum Pharmaceuticals | ARS: Annual Report to Security Holders
Mirum Pharmaceuticals | DEFA14A: Others
Mirum Pharmaceuticals | DEF 14A: Definitive information statements
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer BJERKHOLT ERIC
Mirum Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Radovich Peter
Analysis
Price Target
No Data
